Complex Genetics of Alzheimer's Disease Group, VIB-UAntwerp Center for Molecular Neurology, University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610, Antwerp, Belgium.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Acta Neuropathol. 2024 Oct 18;148(1):55. doi: 10.1007/s00401-024-02815-w.
Alzheimer's disease (AD) is the leading cause of dementia worldwide. Besides neurofibrillary tangles and amyloid beta (Aβ) plaques, a wide range of co-morbid neuropathological features can be observed in AD brains. Since AD has a very strong genetic background and displays a wide phenotypic heterogeneity, this study aims at investigating the genetic underpinnings of co-morbid and hallmark neuropathological lesions. This was realized by obtaining the genotypes for 75 AD risk variants from low-coverage whole-genome sequencing data for 325 individuals from the Leuven Brain Collection. Association testing with deeply characterized neuropathological lesions revealed a strong and likely direct effect of rs117618017, a SNP in exon 1 of APH1B, with tau-related pathology. Second, a relation between APOE and granulovacuolar degeneration, a proxy for necroptosis, was also discovered in addition to replication of the well-known association of APOE with AD hallmark neuropathological lesions. Additionally, several nominal associations with AD risk genes were detected for pTDP pathology, α-synuclein lesions and pTau-related pathology. These findings were confirmed in a meta-analysis with three independent cohorts. For example, we replicated a prior association between TPCN1 (rs6489896) and LATE-NC risk. Furthermore, we identified new putative LATE-NC-linked SNPs, including rs7068231, located upstream of ANK3. We found association between BIN1 (rs6733839) and α-synuclein pathology, and replicated a prior association between USP6NL (rs7912495) and Lewy body pathology. Additionally, we also found that UMAD1 (rs6943429) was nominally associated with Lewy body pathology. Overall, these results contribute to a broader general understanding of how AD risk variants discovered in large-scale clinical genome-wide association studies are involved in the pathological mechanisms of AD and indicate the importance of downstream elimination of phenotypic heterogeneity introduced in these studies.
阿尔茨海默病(AD)是全球范围内导致痴呆的主要原因。除了神经纤维缠结和淀粉样β(Aβ)斑块外,AD 大脑中还可以观察到广泛的共病神经病理学特征。由于 AD 具有很强的遗传背景,并表现出广泛的表型异质性,因此本研究旨在研究共病和标志性神经病理学病变的遗传基础。这是通过从莱顿脑库的 325 个人的低覆盖全基因组测序数据中获得 75 个 AD 风险变体的基因型来实现的。对深度特征化的神经病理学病变进行关联测试显示,APH1B 外显子 1 中的 SNP rs117618017 与tau 相关病理学具有很强且可能直接的影响。其次,除了 APOE 与 AD 标志性神经病理学病变的关联得到复制外,还发现了 APOE 与颗粒空泡变性(坏死性凋亡的一种替代物)之间的关系。此外,还检测到几个与 AD 风险基因的名义关联,用于 pTDP 病理学、α-突触核蛋白病变和 pTau 相关病理学。这些发现通过与三个独立队列的荟萃分析得到了证实。例如,我们复制了 TPCN1(rs6489896)与 LATE-NC 风险之间的先前关联。此外,我们确定了新的潜在 LATE-NC 相关 SNPs,包括位于 ANK3 上游的 rs7068231。我们发现 BIN1(rs6733839)与α-突触核蛋白病理学之间存在关联,并复制了 USP6NL(rs7912495)与 Lewy 体病理学之间的先前关联。此外,我们还发现 UMAD1(rs6943429)与 Lewy 体病理学具有名义上的关联。总的来说,这些结果有助于更广泛地了解在大规模临床全基因组关联研究中发现的 AD 风险变体如何参与 AD 的病理机制,并表明消除这些研究中引入的表型异质性的重要性。